SECsense Logo

Revelation Biosciences, Inc. 8-K Report: Equity Structures & Stock Insights

$REVB
Form 8-K
Filed on: 2025-02-11
Source
Revelation Biosciences, Inc. 8-K Report: Equity Structures & Stock Insights

Here are the key insights extracted from the provided financial report section:

  1. Entity Information: The financial report pertains to Revelation Biosciences, Inc., identified by CIK number 0001810560.
  2. Reporting Date: The report is relevant for the period starting and ending on February 10, 2025.
  3. Stock Information:
  • Common Stock: The common stock has a par value of $0.001 per share and is traded on the NASDAQ under the ticker symbol REVB.
  • Redeemable Warrants:
    • Each warrant is exercisable for a 1/16,800th share of common stock.
    • The exercise price for the warrants is set at $193,200.00 per share.
    • These warrants are listed on NASDAQ with the symbol REVBW.
  1. Corporate Structure: The mention of common stock and redeemable warrants indicates potential equity structures and financing mechanisms utilized by the company.
  2. Contact Information: The company is located at 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122, and can be reached at (650) 800-3717.
  3. Filing Type: The document references an 8-K filing, which is typically used to disclose significant events that shareholders should know about.

Overall, the report sheds light on the company's equity structure, including common stock and redeemable warrants, as well as basic corporate information and the specific filing type.